R. A. Rudick

Medicine · Health Sciences

18h-index2.4kcitations28works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(20), Peripheral Neuropathies and Disorders(5), Systemic Lupus Erythematosus Research(4), Rheumatoid Arthritis Research and Therapies(3), Monoclonal and Polyclonal Antibodies Research(2)

Publications28 total

Regional White Matter Tissue Damage Predicts Local Cortical Thinning in Multiple Sclerosis (S51.002)
Neurology·2012
FP39-WE-02 A 15-year follow-up study to identify early predictors of long-term response to intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis
Journal of the Neurological Sciences·2009· 6 cited
The kinetics of brain atrophy during the first year of treatment with natalizumab
UCL Discovery (University College London)·2007· 1 cited
The incidence and significance of anti-natalizumab antibodies
Neurology·2007· 329 cited
Optimal reference population for the multiple sclerosis functional composite
Multiple Sclerosis Journal·2007· 29 cited
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis
Neurology·2007· 128 cited
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis
Neurology·2005· 164 cited
The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials
Multiple Sclerosis Journal·2002· 230 cited
Immunomodulatory effects of interferon beta-1a in multiple sclerosis
Journal of Neuroimmunology·2001· 101 cited
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patients
Multiple Sclerosis Journal·2000· 23 cited
Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials
Multiple Sclerosis Journal·1998· 24 cited
Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis
Neurology·1998· 331 cited
Magnetic resonance studies of intramuscular interferon β–1a for relapsing multiple sclerosis
Annals of Neurology·1998· 334 citedOpen Access
Devic's disease: Diagnostic and therapeutic challenge
Multiple Sclerosis Journal·1997· 1 cited
A Replicated Prospective Investigation of Life Stress, Coping, and Depressive Symptoms in Multiple Sclerosis
Journal of Behavioral Medicine·1997· 132 cited
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis
Neurology·1997· 232 cited
Changes in the expanded disability status score with interferon beta-1A-treatment for relapsing multiple sclerosis
Multiple Sclerosis Journal·1996
Low-dose oral methotrexate in chronic progressive multiple sclerosis
Neurology·1996· 75 cited
Cerebrospinal fluid in acute optic neuritis
Neurology·1996· 75 cited
Results of a phase III trial of IM recombinant beta interferon as treatment for MS
Journal of Neuroimmunology·1994· 6 cited
page 1 of 2Next →

Frequent Co-authors

Donald E. Goodkin(10), Diane L. Cookfair(6), Jill S. Fischer(6), Bianca Weinstock‐Guttman(6), Jack H. Simon(5), Michele Mass(5), J R Richert(5), Nancy A. Simonian(4), Robert M. Herndon(4), Andres Μ. Salazar(4), John Alam(4), Dennis Bourdette(4), Michael E. Coats(4), L. D. Jacobs(4), Jonathan Braiman(3), Carol M. Brownscheidle(3), Stanley Cohan(3), Barbara Scherokman(3), Ruth H. Whitham(3), M. Campion(3)